Buccal Drug Delivery Market is Booming Worldwide with a USD 7.13 billion by 2030 at a CAGR of 9.8%

Buccal Drug Delivery Market analysis report covers detailed value chain analysis of the market. The value chain analysis helps to analyze major upstream raw materials, major equipment’s, manufacturing process, and downstream customer analysis and major distributor analysis are mentioned in the report along with all the drivers and restraints for the market. It presents a comparative detailed analysis of all regional and player segments, offering readers a better knowledge of the areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the market.

Buccal drug delivery systems have gained huge growth because of the constant research and development in this field. Buccal delivery is considered the most feasible and preferred choice compared to oral dosage form, particularly among elderly patients. The sublingual films segment is projected to grow at the highest rate during the forecast period 2023-2030. The market is still developing in terms of new product launches because of the limited identification of suitable drug candidates.

Data Bridge Market Research analyses a growth rate in the buccal drug delivery market in the forecast period 2023-2030. The expected CAGR of buccal drug delivery market is tend to be around 9.8% in the mentioned forecast period. The market value is USD 3.38 billion in 2022, and it would grow upto USD 7.13 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Buccal drug delivery is a substitute technique for an oral drug delivered in which the drug is administrated through buccal mucosa of oral cavity. The drug is usually placed between the upper gums and cheeks for the treatment of numerous disease and condition. Buccal drug delivery is considered suitable for use among the hospital patients. The biofluid interaction of the buccal drug delivery is reduced by such delivery systems. These systems even help in providing high concentration particularly at target area.

Download Exclusive Sample Report (Including Graphs, Charts & Table & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-buccal-drug-delivery-market

Buccal Drug Delivery Market Dynamics

Drivers

Increasing research by Different Community Hospitals

Rise in admission in hospitals, particularly of elderly patients, and product development and research by numerous community hospitals are increasing the segment growth. Studies conducted by several hospitals bring novelty and increase the commercialization of the formulation. For instance, three community hospitals in Japan in 2020 conducted in vitro and in vivo studies to develop mucoadhesive microparticle-laden gels for oral mucositis. The research confirmed that the drug’s increased concentration at the target site and faster treatment than traditional dosage forms are most likely to improve the adoption. Furthermore, several hospitals in highly developed countries are much involved in the study and development of buccal mucoadhesive formulation which includes potent analgesics, insulin, and drugs to treat heart failure. Ambulatory centers are anticipated to witness the huge growth during the forecast period, followed by the other segment that includes home health, clinics, and OTC medications.

Opportunities

Increasing Demand of Sublingual Films

The sublingual films are anticipated to grow at the highest rate during the forecast period 2023-2030. Multiple factors are responsible for the segment’s growth, such as increased research to develop controlled release formulation and immediate availability of high drug concentration at a target site. These formulations are used widely being used in anti-addiction treatments and emergency care centers due to their faster onset of action.

Increase in Smoking Addiction

Buccal drug delivery is often the most recommended and effective formulation for treating patients with smoking or nicotine addiction. Several studies have confirmed that nicotine lozenges are highly effective in delivering a greater concentration of the drug than gums or other dosage forms. It is also a good alternative for those hesitant to constantly chew on gums and a great choice to cease low and high-dependent smoking. Thus, this factor boost the market growth.

Global Buccal Drug Delivery Market Scope

The buccal drug delivery market is segmented on the basis of indication, type, design, forms, drugs, end-users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Indication

Pain Management

Smoking Cessation

Angina Pectoris

Cough

Others  

Type

Non-Attached Drug Delivery Systems

Bio-Adhesive Drug Delivery Systems  

Design

Matrix Type

Reserviour Type

Forms

Solid Buccal Adhesive Dosage Forms

Buccal tablets

Wafers

Lozenges

Semi-Solid Buccal Adhesive Dosage Forms

Gels

Buccal patches

Buccal films

Liquid Buccal Adhesive Dosage Forms

Drugs

Oral Bioadhesive Formulation

Hydrocartisone succinate

Hypromellose

Miconazole

Chlorohexidine

Sublingual Formulation

Glycerin trinitrate

Others

Others

End-Users

Hospitals

Homecare

Specialty Clinics

Others

To Get a Detailed Table of Contents (TOC), please Click Here at @ https://www.databridgemarketresearch.com/toc/?dbmr=global-buccal-drug-delivery-market

Buccal Drug Delivery Market Regional Analysis/Insights

The buccal drug delivery market is analyzed and market size insights and trends are provided by indication, type, design, forms, drugs, end-users as referenced above.

The major countries covered in the buccal drug delivery market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the buccal drug delivery market because of the wide presence of a large number of major market players, improved research to identify suitable drug candidates, major investment by major market players to improve the development of innovative formulations, and improved diagnosis.

Asia-Pacific is considered to have the most lucrative growth because of increase in the elderly population, the huge development of pharmaceutical industry, and a massive increase in market players.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Global Buccal Drug Delivery Market Share Analysis

The buccal drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to buccal drug delivery market.

Key players operating in the buccal drug delivery market include:

Pfizer Inc. (U.S.)

Lupin (India)

Teva Pharmaceuticals Industries Ltd. (Israel)

Zydus Group (India)

Bausch Health Companies Inc (Canada)

Collegium Pharmaceutical, Inc. (U.S.)

GSK plc (U.K.)

Abbvie, Inc (U.S.)

AstraZeneca (U.K.)

F. Hoffmann-La Roche Ltd. (Switzerland)

Mylan N.V. (U.S.)

Dr. Reddy’s Laboratories Ltd (India)

Endo International plc (Ireland)

Sanofi (France)

Bayer AG (Germany)

Takeda Pharmaceutical Company Limited (Japan)

Novartis AG (Switzerland)

Indivior PLC (U.S.)

Novo Nordisk A/S (Denmark)

NAPP PHARMACEUTICALS LIMITED (U.S.)

APR (Switzerland)

ARKRAY, Inc (Japan)

Browse Detailed Summary of Research Report @ https://www.databridgemarketresearch.com/reports/global-buccal-drug-delivery-market

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Top Trendings Reports:-

https://www.databridgemarketresearch.com/reports/global-vendor-neutral-archive-vna-market

https://www.databridgemarketresearch.com/reports/global-anesthesia-monitoring-devices-market

https://www.databridgemarketresearch.com/reports/global-point-of-care-molecular-diagnostics-market

https://www.databridgemarketresearch.com/reports/global-cell-permeabilization-market

https://www.databridgemarketresearch.com/reports/global-tangential-flow-filtration-market

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability levels and advanced approaches. We are committed to uncovering the best consumer prospects and fostering useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expanded its reach by opening a new office in the Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”

Contact us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com